Emapalumab Extends 'Intervention-Free' Survival for Children with HLH

Emapalumab improves stem cell transplant outcomes for children with hemophagocytic lymphohistiocytosis (HLH), reducing mixed chimerism and enhancing intervention-free survival, according to a study published in the journal Blood.